PHMMF (Pharma Mar) Cyclically Adjusted Book per Share: $8.41 (As of Mar. 2026)


PHMMF Pharma Mar SA PHMMF
82 GF Score
Price $79.49
GF Value $90.53
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Pharma Mar Cyclically Adjusted Book per Share?

Pharma Mar PHMMF -25.35% 82 Cyclically Adjusted Book per Share is $8.41 as of Mar. 2026. GuruFocus rates PHMMF with a GF Score™ of 82/100 and a GF Value™ of $90.53 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Pharma Mar's adjusted book value per share for the three months ended in Mar. 2026 was $16.678. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $8.41 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Pharma Mar's average Cyclically Adjusted Book Growth Rate was 13.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 15.90% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 21.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Pharma Mar was 26.10% per year. The lowest was -12.10% per year. And the median was 15.90% per year.

As of today (2026-06-29), Pharma Mar's current stock price is $79.49. Pharma Mar's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $8.41. Pharma Mar's Cyclically Adjusted PB Ratio of today is 9.45.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pharma Mar was 49.07. The lowest was 3.90. And the median was 11.05.


Pharma Mar  (OTCPK:PHMMF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Pharma Mar's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=79.49/8.41
=9.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pharma Mar was 49.07. The lowest was 3.90. And the median was 11.05.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Pharma Mar Cyclically Adjusted Book per Share Related Terms


Pharma Mar Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Pharma Mar's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Mar Cyclically Adjusted Book per Share Chart

Pharma Mar Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.01 5.15 6.44 6.62 8.55

Pharma Mar Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.31 8.13 8.01 8.55 8.41

PHMMF vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Pharma Mar's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Mar Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Mar's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Pharma Mar's Cyclically Adjusted PB Ratio falls into.


PHMMF
82GF Score
Pharma Mar SA PHMMF
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharma Mar Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pharma Mar's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=16.678/128.4016*128.4016
=16.678

Current CPI (Mar. 2026) = 128.4016.

Pharma Mar Quarterly Data

Book Value per Share CPI Adj_Book
201606 3.807 100.333 4.872
201609 3.655 99.737 4.705
201612 2.999 101.842 3.781
201703 2.902 100.896 3.693
201706 2.874 101.848 3.623
201709 2.533 101.524 3.204
201712 1.724 102.975 2.150
201803 1.708 102.122 2.148
201806 1.902 104.165 2.345
201809 2.034 103.818 2.516
201812 1.319 104.193 1.625
201903 0.698 103.488 0.866
201906 0.008 104.612 0.010
201909 -0.316 103.905 -0.391
201912 0.683 105.015 0.835
202003 4.860 103.469 6.031
202006 6.585 104.254 8.110
202009 6.367 103.521 7.897
202012 6.899 104.456 8.481
202103 8.364 104.857 10.242
202106 8.952 107.102 10.732
202109 9.354 107.669 11.155
202112 11.162 111.298 12.877
202203 12.340 115.153 13.760
202206 12.091 118.044 13.152
202209 11.619 117.221 12.727
202212 13.043 117.650 14.235
202303 12.923 118.948 13.950
202306 12.674 120.278 13.530
202309 12.368 121.343 13.087
202312 11.958 121.300 12.658
202403 11.962 122.762 12.512
202406 11.132 124.409 11.489
202409 11.637 123.121 12.136
202412 12.414 124.753 12.777
202503 12.196 125.531 12.475
202506 13.334 127.251 13.455
202509 13.497 126.842 13.663
202512 16.987 128.402 16.987
202603 16.678 128.402 16.678

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $8.41 mean?
Pharma Mar (PHMMF) has a Cyclically Adjusted Book per Share of $8.41 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Pharma Mar and its competitors.
Is Pharma Mar's Cyclically Adjusted Book per Share too high?
Pharma Mar's current Cyclically Adjusted Book per Share is $8.41. Overall, Pharma Mar has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pharma Mar's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Pharma Mar's Cyclically Adjusted Book per Share of $8.41 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Pharma Mar and its competitors. Pharma Mar's current Cyclically Adjusted Book per Share is $8.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma Mar stock overvalued right now?
Based on GuruFocus' analysis, Pharma Mar (PHMMF) is currently considered Modestly Undervalued. The stock's GF Value™ is $90.53, compared to a current price of $79.49 — trading 12.2% below its estimated fair value. The current Cyclically Adjusted Book per Share is $8.41. Pharma Mar's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Pharma Mar (PHMMF), the current Cyclically Adjusted Book per Share is $8.41 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharma Mar (PHMMF) Overvalued in 2026?

Based on GuruFocus' analysis, Pharma Mar stock appears to be undervalued. The current stock price of $79.49 is trading 12.2% below its estimated GF Value™ of $90.53. GuruFocus considers Pharma Mar to be Modestly Undervalued.

Key valuation signals for PHMMF:

  • Cyclically Adjusted Book per Share: $8.41
  • GF Value™: $90.53 vs. price of $79.49 (12.2% below fair value)
  • GF Score™: 82/100 with 3 warning signs

No single metric tells the full story. See the PHMMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pharma Mar Business Description

Address Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.
82GF Score

Get the complete analysis for PHMMF

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$79.49
Price
$90.53
GF Value